Esomeprazole Market Size, Share, Global Analysis Report 2024-2032
Esomeprazole Market Size, Share, Global Analysis Report 2024-2032

Esomeprazole Market Share, Size, Trends, Industry Analysis Report, By Product (Capsules, Tablets, Injections, Others); By Application; By Distribution Channel; By Region; Segment Forecast, 2024 - 2032

  • Published Date:Feb-2024
  • Pages: 116
  • Format: PDF
  • Report ID: PM4436
  • Base Year: 2023
  • Historical Data: 2019 – 2022

Report Outlook

Esomeprazole Market size was valued at USD 1,810.61 million in 2023. The market is anticipated to grow from USD 1,904.40 million in 2024 to USD 2,872.07 million by 2032, exhibiting the CAGR of 5.3% during the forecast period.

Market Overview

Esomeprazole is witnessing a rapid surge in demand in the global space, driven by an increasingly aging population and a changing lifestyle. In the current generation, people are going through hectic work schedules with no time for maintaining a perfect diet, leading to health complications related to the digestive system and acidity disorders. This contributes to the necessity of the medication's ability to lower acid levels in the stomach. The increasing number of research studies is expected to provide new growth opportunities in the coming years.

●      For instance, in December 2023, a study published in BMC Gastroenterology focused on evaluating the efficiency and safety of dual delayed-release esomeprazole and delayed-release esomeprazole in treating erosive esophagitis. Results suggested that both are similarly effective in treating the disease.

Moreover, the rising number of acid reflux cases among adults is anticipated to drive demand for significant medications associated with it, including esomeprazole, as it has tremendous potential for controlling acid burning. According to the Fortune Clinic, Mumbai, in 2023, approximately 20% of the patients in their outpatient department are suffering from acid reflux cases on a weekly basis. As this trend continues, the demand for esomeprazole is expected to rise further during the study period.

Esomeprazole Market Size

To Understand More About this Research: Request a Free Sample Report

However, the higher costs of production of esomeprazole medicine and rising conflicts related to the patent rights of this drug are expected to impede the growth of the market in the coming years.

Growth Drivers

Rising gastroenteritis cases drives the market

The rising incidence of health problems associated with the stomach is facilitating a new demand for esomeprazole medicine. According to data from city hospitals, in April 2023, there was a 25 to 30% rise in the number of patients taking treatment due to a rise in gastroenteritis cases over the past couple of weeks. This is due to the increasing intake of contaminated water and food in the summer. The rising gastroenteritis cases are anticipated to facilitate significant demand for this medicine in the future, according to the esomeprazole market forecast.

The changing eating patterns and rising obesity drives the market

The changing consumer eating habits, alcohol and coffee consumption, and smoking are some of the major factors leading to acid reflux cases. The rising obesity cases in the global space are expected to fuel the need for this drug in the marketplace. According to a study, there is a significant correlation between obesity and the symptoms of gastroesophageal reflux disease (GERD). Women with a body mass index of 25-29.9, who are considered overweight, are more than twice as likely to develop acid reflux compared to those with a normal weight.

Restraining Factors

The side-effects associated with esomeprazole are likely to hinder market growth

The increased accessibility to the Internet is encouraging patients to research medicines before intake. This provided a platform to learn about the side effects and functioning of medication in the human body. The Indian Pharmacopoeia Commission’s Pharmacovigilance Program of India (PvPI) evaluated the esomeprazole drug and revealed the chance of getting hyperprolactinemia as it can lower prolactin levels.

Report Segmentation

The market is primarily segmented based on product, application, distribution channel and region.

By Product

By Application

By Distribution Channel

By Region

  • Capsules
  • Tablets
  • Injections
  • Others

 

  • Gastroesophageal reflux disease
  • Erosive Esophagitis
  • Peptic Ulcers
  • Duodenal Ulcers
  • Zollinger-Ellison Syndrome
  • Others

 

  • Hospitals & Clinical Pharmacies
  • Online Pharmacies
  • OTC

 

 

  • North America (U.S., Canada)
  • Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
  • Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
  • Latin America (Brazil, Mexico, Argentina)
  • Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

To Understand the Scope of this Report: Speak to Analyst

By Product Analysis

Capsules segment is expected to register the highest growth in the study period

The capsules segment is anticipated to grow at a higher CAGR during the study period, primarily driven by the availability of esomeprazole capsules in the retail space and the rising number of companies offering esomeprazole capsules, which is attributable to the increasing drug production approvals by the US FDA. Furthermore, the ability to act faster than tablets and other product types is contributing to segment growth.

The tablets segment led the industry market with a substantial revenue share in 2023, largely attributable to its ability to cost-effectiveness and higher familiarity with the tablets.

By Application Analysis

Gastroesophageal reflux disease segment witnessed the largest market share in 2023

The GERD segment registered the largest market share in 2023. The rising incidence of GERD in more countries is boosting the expansion of the esomeprazole market size. According to a study, it is one of the most highly diagnosed digestive disorders, with a prevalence rate of 20% in the United States. This trend is a major factor contributing to the larger market share of GERD in the esomeprazole market analysis.

The peptic ulcers segment is expected to grow at the fastest rate over the next few years on account of the significant rise in peptic ulcers. The prevalence of peptic ulcer diseases was 10% in 1990, with 500,000 new cases annually in the United States. 

By Distribution Channel Analysis

Hospitals & Clinical Pharmacies segment registered a significant market revenue share in 2023

Hospitals and clinical pharmacies segment held the largest share in 2023 due to the prevalence of peptic ulcers, GERD, and other disease cases in healthcare settings. The increased accessibility of hospitals in the countries, from rural areas to urban areas, is a significant rise in consultation with doctors in most health conditions, driven by government initiatives to promote healthcare infrastructure in their countries. This necessitates the requirements of esomeprazole in the marketplace.

Regional Insights

North America region registered the largest share of the global market in 2023

The North America region dominated the market. This is largely influenced by the rising prevalence of GERD and peptic ulcers in the region. The Asia Pacific region is projected to be the fastest-growing region with a healthy CAGR during the study period, owing to the growing elderly population and rising gastroesophageal reflux cases. The growing company engaging in the production of this drug in the region is expected to impact market growth positively. For instance, in 2022, Sun Pharma received approval from the Central Drug Standard Organization to produce Esomeprazole dual-release gastro-resistant tablets. 

Key Market Players & Competitive Insights

Strategic acquisitions to drive the competition

The esomeprazole market share is moderately fragmented and is expected to witness competition due to the presence of several market players. The key market players are showing enormous interest in strategic collaborations, partnerships, and acquisitions in the market. For instance, in December 2022, LG Chem acquired the patent rights for Vimovo, which was developed by AstraZeneca by utilising naproxen and esomeprazole as ingredients.

Some of the major players operating in the global market include:

  • Actavis (US)
  • AstraZeneca AB (UK)
  • Blaskov (Columbia)
  • CQ Lummy (China)
  • KernPharm (Spain)
  • Mepha (India)
  • Mylan (US)
  • Sandoz (Switzerland)
  • Sanofi (France)
  • Saval Pharmaceutical (Chile)
  • Stada Arzneimittel AG (Germany)
  • Teva Pharmaceuticals (Israel)

Recent Developments in the Industry

  • In October 2023, Zydus Lifesciences Limited announced the final approval of esomeprazole magnesium for delayed-release oral suspension, 20mg and 40 mg, from the US FDA.

Report Coverage

The esomeprazole market report emphasizes on key regions across the globe to provide better understanding of the product to the users. Also, the report provides market insights into recent developments, trends and analyzes the technologies that are gaining traction around the globe. Furthermore, the report covers in-depth qualitative analysis pertaining to various paradigm shifts associated with the transformation of these solutions.

The report provides detailed analysis of the market while focusing on various key aspects such as competitive analysis, product, application, distribution channel, and their futuristic growth opportunities.

Esomeprazole Market Report Scope

Report Attributes

Details

Market size value in 2024

USD 1,904.40 million

Revenue forecast in 2032

USD 2,872.07 million

CAGR

5.3% from 2024 – 2032

Base year

2023

Historical data

2019 – 2022

Forecast period

2024 – 2032

Quantitative units

Revenue in USD million and CAGR from 2024 to 2032

Segments covered

  • By Product
  • By Application
  • By Distribution Channel
  • By Region

Regional scope

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Competitive Landscape

  • Esomeprazole Market Share Analysis (2023)
  • Company Profiles/Industry participants profiling includes company overview, financial information, product/service benchmarking, and recent developments

Report Format

  • PDF + Excel

Customization

Report customization as per your requirements with respect to countries, region and segmentation.

FAQ's

The Esomeprazole Market report covering key segments are product, application, distribution channel and region.

Esomeprazole Market Size Worth $2,872.07 Million By 2032

Esomeprazole Market exhibiting the CAGR of 5.3% during the forecast period.

North America is leading the global market

key driving factors in Esomeprazole Market are Rising gastroenteritis cases drives the market